A case of allopurinol-induced fixed drug eruption confirmed with a lymphocyte transformation test
- PMID: 22950038
- PMCID: PMC3423606
- DOI: 10.4168/aair.2012.4.5.309
A case of allopurinol-induced fixed drug eruption confirmed with a lymphocyte transformation test
Abstract
Allopurinol is one of the causative drugs that induce fixed drug eruption (FDE). The lymphocyte transformation test (LTT) is a safe and reliable diagnostic procedure for drug allergy, but is reported to be rarely positive in patients with FDE. In the current case, we performed an LTT and successfully confirmed allopurinol as the offending drug. This case report suggests that an LTT should be an optional diagnostic tool for FDE or delayed reaction due to allopurinol.
Keywords: Allopurinol; fixed drug eruption; lymphocyte transformation test.
Conflict of interest statement
There are no financial or other issues that might lead to conflict of interest.
Figures
References
-
- Shiohara T. Fixed drug eruption: pathogenesis and diagnostic tests. Curr Opin Allergy Clin Immunol. 2009;9:316–321. - PubMed
-
- Andrade P, Brinca A, Gonçalo M. Patch testing in fixed drug eruptions--a 20-year review. Contact Dermatitis. 2011;65:195–201. - PubMed
-
- Nyfeler B, Pichler WJ. The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity. Clin Exp Allergy. 1997;27:175–181. - PubMed
-
- Kano Y, Hirahara K, Mitsuyama Y, Takahashi R, Shiohara T. Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption. Allergy. 2007;62:1439–1444. - PubMed
-
- Umpiérrez A, Cuesta-Herranz J, De Las Heras M, Lluch-Bernal M, Figueredo E, Sastre J. Successful desensitization of a fixed drug eruption caused by allopurinol. J Allergy Clin Immunol. 1998;101:286–287. - PubMed
LinkOut - more resources
Full Text Sources